Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:30 pm Sale | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 3,406,335 11.700% | -597,632 (-14.93%) | View |
| 2024-11-14 3:36 pm Purchase | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I L.P. | 2,433,168 8.200% | 400 (+0.02%) | View |
| 2024-11-04 4:51 pm Purchase | 13G | NeuroPace, Inc. NPCE | Kent Lake PR LLC | 1,472,491 5.000% | 1,472,491 (New Position) | View |
| 2024-10-03 4:46 pm Sale | 13G | NeuroPace, Inc. NPCE | KCK LTD. | 5,554,089 19.000% | -39,684 (-0.71%) | View |
| 2024-02-14 7:00 pm Sale | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,003,967 15.200% | -8,314 (-0.21%) | View |
| 2024-02-14 4:15 pm Sale | 13G | NeuroPace, Inc. NPCE | KCK LTD. | 5,593,773 21.300% | -27,338 (-0.49%) | View |
| 2024-02-09 1:25 pm Purchase | 13G | NeuroPace, Inc. NPCE | MORGAN STANLEY MS | 2,460,716 9.400% | 272,123 (+12.43%) | View |
| 2024-02-09 09:28 am Sale | 13G | NeuroPace, Inc. NPCE | FMR LLC | 468,081 1.780% | -981,845 (-67.72%) | View |
| 2024-02-02 09:20 am Purchase | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I L.P. | 2,432,768 9.300% | 63,765 (+2.69%) | View |
| 2023-02-14 4:48 pm Unchanged | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.100% | 0 (Unchanged) | View |
| 2023-02-14 08:22 am Purchase | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I L.P. | 2,369,003 9.500% | 60,000 (+2.60%) | View |
| 2023-02-10 1:12 pm Purchase | 13G | NeuroPace, Inc. NPCE | MORGAN STANLEY MS | 2,188,593 8.800% | 2,188,593 (New Position) | View |
| 2023-02-09 12:01 pm Purchase | 13G | NeuroPace, Inc. NPCE | FMR LLC | 1,449,926 5.822% | 1,449,926 (New Position) | View |
| 2022-11-23 5:11 pm Purchase | 13D | NeuroPace, Inc. NPCE | Accelmed Partners II L.P. | 4,432,948 17.800% | 390,291 (+9.65%) | View |
| 2022-11-21 07:00 am Purchase | 13D | NeuroPace, Inc. NPCE | Accelmed Partners II L.P. | 4,042,657 16.200% | 4,042,657 (New Position) | View |
| 2022-10-07 4:49 pm Purchase | 13G | NeuroPace, Inc. NPCE | KCK LTD. | 5,621,111 22.990% | 5,621,111 (New Position) | View |
| 2022-02-11 4:35 pm Unchanged | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.500% | 0 (Unchanged) | View |
| 2022-02-10 5:00 pm Purchase | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I L.P. | 2,309,003 9.500% | 473,663 (+25.81%) | View |
| 2022-01-13 4:23 pm Sale | 13G | NeuroPace, Inc. NPCE | Medtronic plc MDT | 965,936 3.970% | -300,000 (-23.70%) | View |
| 2021-11-01 5:16 pm Purchase | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I L.P. | 1,835,340 7.600% | 1,835,340 (New Position) | View |